-
Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS)
Houda, I., Naves, D., Ulas, E. B., Lissenberg-Witte, B. I., Barlo, N. P., Kastelijn, E. A., Bouhaddou, H., Shaikh, R., Dickhoff, C., Radonic, T., Schneiders, F. L., Senan, S., Damhuis, R. A. M. & Bahce, I., 17 Nov 2025, In: Eur. J. Cancer. 230, 116042.Research output: Contribution to journal › Article › Academic › peer-review
-
The role of perioperative chemoimmunotherapy in resectable non-small cell lung cancer: insights from the NADIM trial
de Koning, A., Houda, I., Ulas, E. B. & Bahce, I., 31 Jul 2025, In: Translational lung cancer research. 14, 7, p. 2383-2386 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: The INCREASE study
Bahce, I., Dickhoff, C., Schneiders, F. L., Veltman, J., Heineman, D. J., Hashemi, S. M. S., Vrijmoet, A., Houda, I., Ulas, E. B., Bakker, J., van de Ven, P., Bouwhuis, N., Meijboom, L. J., Oprea-Lager, D. E., van Maldegem, F., Fransen, M. F., de Gruijl, T. D., Radonic, T. & Senan, S., 30 Sept 2024, In: Journal for Immunotherapy of Cancer. 12, 9, e009799.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
